Stay updated on INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial

Sign up to get notified when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T16:33:53.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-05-15T11:04:34.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-05-08T07:27:53.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T04:14:50.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-04-23T19:45:04.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed information about the INTEGA study and its treatment options for advanced esophagogastric adenocarcinoma, while adding new identifiers and collaborators related to gastric cancer research.
    Difference
    39%
    Check dated 2025-04-16T14:34:21.000Z thumbnail image

Stay in the know with updates to INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.